---
category: news
title: "CAR-T cell therapy in oncology"
excerpt: "First generation CAR-T cell therapy is a novel technology in which T cells derived from patientâ€™s blood are engineered ex vivo to express artificial receptors targeted to cell surface tumour antigens, such as CD-19, CD20 and CD22, found predominantly in ..."
publishedDateTime: 2022-10-24T13:32:00Z
originalUrl: "https://www.pmlive.com/pharma_intelligence/CAR-T_cell_therapy_in_oncology_1456834"
webUrl: "https://www.pmlive.com/pharma_intelligence/CAR-T_cell_therapy_in_oncology_1456834"
type: article
quality: 39
heat: 39
published: false

provider:
  name: PMLiVE
  domain: pmlive.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.pmlive.com/__data/assets/image/0003/1456833/Cell_Therapy_Managing_chains_of_custody_and_condition.jpeg"
    width: 1280
    height: 769
    isCached: true

secured: "BXGX9RyYVqO+YV7zHDmIj+rgWO0K4w1pYYYZYK0mqT0HpMTL8nrWLHPikANBA71fYuATb/QH4nVLSGBfnqqd77LUt6ZbJ3lBsGbNVHteI2UPMWOw4sOoQVPe3errmlCwVQaEggz+LDHVq8XUA7smv9i0ZFpiISBW98J0d5YsGEeqVKCraVS/+/ts28gqinFylGE6xt7UQ/AL1ww4Cal6WTsl3dCno6tY9acD5xZuFW3li8fdfa6HXvmu+NnVE8kGhcsQZ7UC5LXhSatyjZplwE4kWumac5PRPQuZmjH8os9YHchbk2uzPakWpb6BFAwtJgBkLczoPwv0okvlPO+MDx3RJXZJ7cmTiMlzuMVAcyQ=;a6vxKBuIBeZvN3oLGiMrWg=="
---

